[30] This property allows the convenient preparation of cobalamin analogs with different substituents, via nucleophilic attack on alkyl halides and vinyl halides
Advertisement Article continues below this ad In addition to pain, an abnormal increase in red blood cells, a runny nose, chest pain, a swollen tongue, and fever are additional adverse reactions that may occur after the injection
Interim glycaemic assessment should use fasting plasma glucose, OGTT, or self-monitored blood glucose
Dosage: 2 mg daily via subcutaneous injection
Provides sustained release
It typically peaks during the first one to two weeks at each new dose level and gradually diminishes as the body adapts